Duodenum-preserving pancreatic head resection in 1063 patients for benign, premalignant cystic, and neuroendocrine neoplasms - Short-term surgical outcomes and risk of recurrence - Results of a systematic review
HPB · 2025
DOI: 10.1016/j.hpb.2025.09.002 ↗Kurz gefasst
Systematische Übersicht in der Zeitschrift HPB, 2025. Verfasst von Hans G Beger und 2 weiteren Autor:innen. Beteiligte Einrichtung: c/o University of Ulm, Albert-Einstein-Allee 23, 89081, Ulm, Germany; Centre for Oncologic, Endocrine and Minimal Invasive Surgery, Donau-Klinikum Ne…. Hauptthemen laut MEDLINE: Pancreatic Neoplasms, Pancreatectomy, Neuroendocrine Tumors, Neoplasm Recurrence, Local. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 89 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
BACKGROUND: To prevent malignant transformation to advanced cancer of premalignant cystic neoplasms and neuroendocrine tumors of the pancreatic head, the objective arises whether oncologic multiorgan PD or parenchyma-sparing, duodenum-preserving resection (DPPHR) should be performed. METHODS: Pubmed, Medline, Embase and Cochrane libraries were searched for studies reporting postoperative results and late outcome after DPPHR. Data from 49 cohort studies including 1063 patients were assessed. RESULTS: DPPHR was performed on 374 IPMN, 96 MCN, 154 SPN, 142 SCA, and 145 PNET patients. 90-day mortality was 5 of 1063 patients (0.47 %), pancreatic fistula B/C 15.7 %, biliary fistula 5.9 %. 39 of 228 IPMNs(17.1 %) revealed high-grade dysplasia, 10 of 374 IPMNs micro-carcinoma and 9 minimal invasive carcinoma. None of them developed disease recurrence after total DPPHR in the follow-up time of 42.05 months. 96.2 % of patients followed the postoperative tracking checks. Recurrent tumor, anastomotic or in remote pancreas, was observed in 21 of 374 IPMNs(5.61 %). Disease-specific survival for 2 and 5 years was 99.3 % and 97.3 %, respectively. CONCLUSION: DPPHR for cystic neoplasms and PNETs is a low-risk surgical treatment and leads to cure of patients. Total duodenum- and CBD-preserving pancreatic head resection extends surgeons' skills for treatment of cystic, premalignant neoplasms of the pancreatic head.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- c/o University of Ulm, Albert-Einstein-Allee 23, 89081, Ulm, Germany; Centre for Oncologic, Endocrine and Minimal Invasive Surgery, Donau-Klinikum Neu-Ulm, Germany. Electronic address: hans@beger-ulm.de.
- University of Ulm, Institute for Epidemiology and Medical Biometry, Germany.
- Centre for Oncologic, Endocrine and Minimal Invasive Surgery, Donau-Klinikum Neu-Ulm, Germany.
Zitieren
APA
Beger, H. G., Mayer, B., & Poch, B. (2025). Duodenum-preserving pancreatic head resection in 1063 patients for benign, premalignant cystic, and neuroendocrine neoplasms - Short-term surgical outcomes and risk of recurrence - Results of a systematic review. HPB. https://doi.org/10.1016/j.hpb.2025.09.002
Vancouver
Beger HG, Mayer B, Poch B. Duodenum-preserving pancreatic head resection in 1063 patients for benign, premalignant cystic, and neuroendocrine neoplasms - Short-term surgical outcomes and risk of recurrence - Results of a systematic review. HPB. 2025. doi:10.1016/j.hpb.2025.09.002
BibTeX
@article{Beger2025,
author = {Beger, Hans G and Mayer, Benjamin and Poch, Bertram},
title = {Duodenum-preserving pancreatic head resection in 1063 patients for benign, premalignant cystic, and neuroendocrine neoplasms - Short-term surgical outcomes and risk of recurrence - Results of a systematic review},
journal = {HPB},
year = {2025},
doi = {10.1016/j.hpb.2025.09.002}
}
EUVIMED